Low molecular mass dinitrosyl nonheme-iron complexes up-regulate noradrenaline release in the rat tail artery

BMC Pharmacology

Volumn 2, Issue , 2002, Pages

  Kleschyov, Andrei L ^a,b   Hubert, Gilles ^a   Munzel, Thomas ^b   Stoclet, Jean Claude ^a   Bucher, Bernard ^a  

^a CNRS   (France)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; DINITROSYL IRON CYSTEINE; DINITROSYL IRON THIOSULFATE; FERROUS ION; IRON COMPLEX; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NORADRENALIN; S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; THIOSULFATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; INFLAMMATION; MALE; MOLECULAR WEIGHT; NONHUMAN; NORADRENALIN RELEASE; PATHOPHYSIOLOGY; RAT; TAIL ARTERY; UPREGULATION; VASODILATATION;

EID: 2642584119     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-2-3     Document Type: Article

References (27)

1. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A: EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 1993, 7:1124-1134
2. Kleschyov AL, Muller B, Stoeckel ME, Stoclet JC: Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am J Physiol heart circ physiol 2000, 279:H2743-H2751
3. Rogers PA, Ding H: L-cysteine-mediated destabilization of dinitrosyl iron complexes in proteins. J Biol Chem 2001, 276:30980-30986
4. Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, Giovannini F, Tomasi A, Iannone A: N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001, 5:349-60
5. Boese M, Mordvintcev PI, Vanin AF, Busse R, Mülsch A: S-nitrosation of serum albumin by dinitrosyl-iron complex. J Biol Chem 1995, 270:29244-29249
6. Giannone G, Takeda K, Kleschyov AL: Novel activation of non-selective cationic channels by dinitrosyl-thiosulfate in PC12 cells. J Physiol 2000, 529:735-745
7. Müsch A, Mordvintcev P, Vanin AF, Busse R: The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett 1991, 294:252-256
8. Stoclet JC, Troncy E, Muller B, Brua C, Kleschyov AL: Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system. Exp Opin Invest Drugs 1998, 7:1769-1779
9. Vanin AF, Kleschyov AL: EPR detection and biological implications of nitrosyl non-heme iron complexes. In: Nitric Oxide in Allograft Rejection and Antitumor Defence 1998 49-82
10. Stamler JS, Toone EJ, Lipton SA, Sucher NJ: signals: translocation, regulation, and a consensus motif. Neuron 1997, 18:691-696
11. Gow AJ, Stamler JS: Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 1998, 391:169-73
12. Bauer PM, Buga GM, Fukuto JM, Pegg AE, Ignarro LJ: Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem 2001, 276:34458-34464
13. Buchner E, Gundersen CB: The DnaJ-like cysteine string protein and exocytotic neurotransmitter release. TINS 1997, 20:223-227
14. Manalis RS, Cooper GP: Evoked transmitter release increased by inorganic mercury at frog neuromuscular junction. Nature 1975, 257:690-691
15. Bucher B, Ouedraogo S, Tschöpl M, Paya D, Stoclet JC: Role of the L-arginine-NO pathway and cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol 1992, 107:976-982
16. Bredt DS, Snyder SH: Nitric oxide: a physiologic messenger. Annu Rev Biochem 1994, 63:175-195
17. Egi Y, Matsumura Y, Murata S, Umekawa T, Hisaki K, Takaoka M, Morimoto S: The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther 1994, 269:529-535
18. Toda N, Yoshida K, Okamura T: Analysis of the potentiating action of NG-nitro-L-arginine on the contraction of the dog temporal artery elicited by transmural stimulation of noradrenergic nerves. Naunyn-Schmiedebergs Arch Pharmacol 1991, 343:221-224
19. Schwarz P, Diem R, Dun NJ, Forstermann U: Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 1995, 77:841-848
20. Ohlmann P, Martinez MC, Bucher B, Andriantsitohaina R, Muller B, Schneider F, Stoclet JC: Effect of lipopolysaccharide treatment on neurogenic contraction and noradrenaline release in rat arteries. Fundam Clin Pharmacol 2000, 14:593-600
21. Ouedraogo S, Tschöpl M, Stoclet JC, Bucher B: Effects of cyclic GMP and analogues on neurogenic transmission in the rat tail artery. Br J Pharmacol 1994, 112:867-872
22. Kanner J, Harel S, Granit R: Nitric oxide as an antioxidant. Arch Biochem Biophys 1991, 289:130-136
23. Vanin AF, Malenkova IV, Serezhenkov VA: Iron catalyzes both decomposition and synthesis of S-nitrosothiols: optical and electron paramagnetic resonance studies. Nitric Oxide 1997, 1:191-203
24. Bucher B, Pain L, Stoclet JC, Illes P: Role of cyclic AMP in the prejunctional alpha-2 adrenoceptor modulation of noradrenaline release from the rat tail artery. Naunyn Schmiedeberg's Arch Pharmacol 1990, 342:640-649
25. Gutterman DD: Adventitia-dependent influences on vascular function. Am J Physiol 1999, 277:H1265-H1272
26. Zhang H, Faber JE: Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different alfa-1-adrenoceptor subtypes. Circ Res 2001, 89:815-822
27. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001, 103:2799-804